Surface‐enhanced resonance Raman scattering for the sensitive detection of a tuberculosis biomarker in human serum. (11th October 2018)

• Record Type: Journal Article
• Authors: Owens, Nicholas A.; Pinter, Abraham; Porter, Marc D.
• Is Part Of: Journal of Raman spectroscopy. Volume 50:Number 1(2019)
• Page Start: 15
• Page End: 25
• Publication Date: 2018-10-11
• Subjects: immunoassay -- infectious disease diagnostics -- resonance Raman -- surface‐enhanced Raman scattering -- tuberculosis; Raman spectroscopy -- Periodicals; 535.846
• DOI: 10.1002/jrs.5500
• Languages: English
• ISSNs: 0377-0486

Abstract

Abstract: Improvements in the detection of biomarkers indicative of disease continue to be vital to human health. Toward this end, this paper presents (a) the development and characterization of a biomarker detection strategy based on the inherently stronger signals generated by surface‐enhanced resonance Raman scattering (SERRS), as opposed to surface‐enhanced Raman scattering (SERS); (b) the application of this approach to the detection of mannose‐capped lipoarabinomannan (ManLAM), an antigenic marker indicative of active tuberculosis infection; and (c) a comparison of readout for this SERRS platform to that of the more frequently used approach based on SERS. More specifically, the work detailed herein describes the design and testing of a SERRS immunoassay that incorporates a resonance Raman‐enhanced adlayer of cyanine 5 on a smooth gold capture surface and its application to biomarker detection when "turned on" by the tagging of captured ManLAM with gold nanoparticle labels. The results of these experiments demonstrated an improvement in the detection of ManLAM spiked into human serum in terms of limit of detection by 10× and analytical sensitivity of almost 40× when compared with SERS. Findings also indicate that these improvements arise primarily from the intrinsic increase in signal strength due to the resonance Raman effect and a small but measurable increase in nanoparticle label density. Potential routes to further improve the performance of this approach to immunoassay signal generation are briefly discussed. Abstract : We apply turn‐on surface‐enhanced resonance Raman scattering (SERRS) as a novel detection strategy for a disease biomaker. This paper includes a detailed characterization of this novel sensor and a head‐to‐head performance comparison with a more conventional assay system. Ultimately we realized a 10× improvement in limit of detection and a ~40× improvement in analytical sensitivity.